Skip to main content
HYTN Innovations Inc. logo

HYTN Innovations Inc. — Investor Relations & Filings

Ticker · HYTN ISIN · CA40443L1040 LEI · 894500ZEFRLAROPRBH27 CSE Manufacturing
Open in API
Filings indexed 172 across all filing types
Latest filing 2025-12-18 Regulatory Filings
Country CA Canada
Listing CSE HYTN

About HYTN Innovations Inc.

https://hytn.ca/

HYTN Innovations Inc. formulates and manufactures premium products containing psychoactive and psychotropic compounds, including cannabinoids and psilocybin. Operating a GMP-certified facility, the company specializes in producing Active Pharmaceutical Ingredients (APIs) and finished goods for global pharmaceutical export, holding a Health Canada Drug Establishment License. HYTN is recognized as one of the few global sites certified for the cultivation, processing, and release of psilocybin mushrooms. Its unique selling proposition is the proprietary Elevation Technology®, a nano-emulsification platform that creates stable, highly bioavailable, rapid-onset formulations. For consumer markets, HYTN manufactures and distributes branded cannabis products such as sugar-free beverages, nano-shots, and edibles.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by HYTN Innovations Inc. regarding a U.S. executive order on cannabis reclassification. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a corporate governance or board change announcement. As it is a general corporate announcement regarding regulatory developments and company positioning, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous corporate news.
2025-12-18 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing receipt of a purchase order for GMP vape cartridges and contains forward‐looking statements and standard corporate boilerplate. It does not present financial results (so not an Earnings Release), legal proceedings, share transactions, dividend notices, management changes, or any specific regulated report (e.g., 10-K, IR, audit). It is not a formal investor presentation or proxy statement, nor is it a capital raising announcement. Therefore it does not fit any specific specialized category and is best classified under the fallback “Regulatory Filings” (RNS).
2025-06-11 English
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal “Notice of Meeting and Record Date” for the issuer’s upcoming Annual General Meeting, filed via SEDAR. It provides meeting type, date, record dates, and related voting logistics, which are part of proxy solicitation materials sent to shareholders to inform and request votes. This falls under Proxy Solicitation & Information Statement (PSI), since it is a shareholder meeting notice and voting information rather than the actual AGM materials or a simple regulatory update.
2025-06-06 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CEO, which is a regulatory certificate required under Canadian NI 52-109. It is not the interim report itself (IR) nor an annual report or audit report. It is a statutory certification filing rather than financial statements or management’s MD&A. Therefore it best fits the fallback category for miscellaneous regulatory filings (RNS).
2025-05-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 venture issuer basic certificate – a regulatory certification by the CFO attesting to the accuracy and fair presentation of interim financial statements and MD&A. It is not the interim report itself (IR), nor an audit report (AR), nor purely an announcement of a report (RPA). It is a mandatory regulatory filing/certification under NI 52-109, which does not fit any specialized category. As such it falls into the general regulatory filings fallback category (RNS).
2025-05-30 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is the Management’s Discussion and Analysis (MD&A) for the six months ended March 31, 2025. It provides management’s detailed narrative on financial results, business operations, forward-looking statements, and condensed interim financial statements under NI 51-102 and IFRS. This matches the definition of a Management Report (MDA).
2025-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.